Therefore, all these data suggest that a partial blockade of PDIA3 in T98G cells might attenuate the pro-tumor microglia activation since it tends to reduce the M2 parameters (urea and ARG1) and IL6 release by microglia. Here, ARG1 is linked to neoplasm.